Venous thromboembolism (VTE) is a significant health problem in the general population
but especially in cancer patients. In this review, we discuss the epidemiology and burden of …

Abstract In 1865, Armand Trousseau noted that unexpected or migratory thrombophlebitis
could be a forewarning of an occult visceral malignancy. An analysis by Sack and …

Background and Objectives To explore clinical and safety outcomes of patients with acute
ischemic stroke (AIS) and active cancer after endovascular treatment (EVT). Methods Using …

The most frequent ultimate cause of death is myocardial arrest. In many cases this is due to
myocardial hypoxia, generally arising from failure of the coronary macro‐and …

This review summarizes the evidence on antiphospholipid (aPL) antibodies and related
thromboembolic events in patients with solid tumors. Data sources included Medline …

Background In acute myeloid leukemia (AML), disseminated intravascular coagulation (DIC)
contributes to morbidity and mortality, but the underlying pathomechanisms remain …

Venous thromboembolism (VTE), comprising deep-vein thrombosis and pulmonary
embolism, is a frequent complication in ambulatory cancer patients. Despite the high risk …

Cancer-related venous thromboembolism (VTE) remains a major health problem,
accounting for at least 18% of all cases of VTE. Cancer patients with VTE have worse …

Background: We have previously found that activation of coagulation in patients with various
hematological malignancies was apparently not initiated by tissue factor (TF). Acquired …

Background Recombinant human soluble thrombomodulin (rTM) has been established and
introduced in the clinic as a standard treatment for disseminated intravascular coagulation …